'Intrahepatic cholestatic hepatitis following diagnostic ajmaline challenge'.
Department of Cardiology, Norfolk & Norwich University Hospital, Norwich, UK. gregmellor@me.com
Greg
G
Mellor
Ian
I
Fellows
Ian
I
Williams
D000404:Ajmaline / Q000009:adverse effects*; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001663:Bilirubin / Q000097:blood; D015415:Biomarkers / Q000097:blood; D053840:Brugada Syndrome / Q000175:diagnosis* / Q000503:physiopathology; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D002780:Cholestasis, Intrahepatic / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D012709:Serum Albumin / Q000378:metabolism; D000075462:Serum Albumin, Human; D013997:Time Factors
C422455:ALB protein, human; D000889:Anti-Arrhythmia Agents; D015415:Biomarkers; D012709:Serum Albumin; D000404:Ajmaline; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin; D000075462:Serum Albumin, Human